[go: up one dir, main page]

DE69219136D1 - Flüssiges nahrungsmittel, das 3-guanidinopropionsäure enthält - Google Patents

Flüssiges nahrungsmittel, das 3-guanidinopropionsäure enthält

Info

Publication number
DE69219136D1
DE69219136D1 DE69219136T DE69219136T DE69219136D1 DE 69219136 D1 DE69219136 D1 DE 69219136D1 DE 69219136 T DE69219136 T DE 69219136T DE 69219136 T DE69219136 T DE 69219136T DE 69219136 D1 DE69219136 D1 DE 69219136D1
Authority
DE
Germany
Prior art keywords
guanidinopropionic acid
pct
insulin
provides
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69219136T
Other languages
English (en)
Other versions
DE69219136T2 (de
Inventor
Martin Durham Meglasson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/751,239 external-priority patent/US6008253A/en
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of DE69219136D1 publication Critical patent/DE69219136D1/de
Publication of DE69219136T2 publication Critical patent/DE69219136T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69219136T 1991-08-26 1992-08-19 Flüssiges nahrungsmittel, das 3-guanidinopropionsäure enthält Expired - Fee Related DE69219136T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75055991A 1991-08-26 1991-08-26
US07/751,239 US6008253A (en) 1991-08-26 1991-08-26 Use of 3-guanidinopropionic acid to increase endurance, stamina and exercise capacity in a mammal
PCT/US1992/006776 WO1993003724A1 (en) 1991-08-26 1992-08-19 Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride

Publications (2)

Publication Number Publication Date
DE69219136D1 true DE69219136D1 (de) 1997-05-22
DE69219136T2 DE69219136T2 (de) 1997-08-28

Family

ID=27115296

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69219136T Expired - Fee Related DE69219136T2 (de) 1991-08-26 1992-08-19 Flüssiges nahrungsmittel, das 3-guanidinopropionsäure enthält

Country Status (10)

Country Link
US (1) US5900435A (de)
EP (1) EP0601001B1 (de)
JP (1) JPH06510286A (de)
AT (1) ATE151634T1 (de)
AU (1) AU2479492A (de)
DE (1) DE69219136T2 (de)
DK (1) DK0601001T3 (de)
ES (1) ES2101866T3 (de)
GR (1) GR3023848T3 (de)
WO (1) WO1993003724A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012799A1 (en) * 1990-02-28 1991-09-05 The Upjohn Company Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
JP2000511177A (ja) * 1996-05-21 2000-08-29 ファルマシア・アンド・アップジョン・カンパニー インスリン非依存性糖尿病治療のためのアミノグアニジンカルボキシレート ラクタム類
JP2000514807A (ja) * 1996-07-12 2000-11-07 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー レプチン耐性の新規な治療
EP0974348B1 (de) * 1996-11-08 2008-07-02 Nippon Chemiphar Co., Ltd. Mittel zur verringerung der eigeweidefette
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
US20020004515A1 (en) * 1997-06-18 2002-01-10 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and metformin
US20010049380A1 (en) * 1997-06-18 2001-12-06 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and sulphonylurea
NZ501163A (en) * 1997-06-18 2002-02-01 Smithkline Beecham P Treatment of diabetes with thiazolidinedione and sulphonylurea (glibenclamide, glipizide, gliclazide, glimepiride, tolazamide and tolbutamide
IL133142A0 (en) * 1997-06-18 2001-03-19 Smithkline Beecham Plc Treatment of diabetes with thiazolidinedione and metformin
BR9810186A (pt) * 1997-06-18 2000-08-08 Smithkline Beecham Plc Tratamento de diabete com tiazolidinadiona e inibidor de alfa-glicosidade
GB9715306D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
US20020016287A1 (en) * 1997-07-18 2002-02-07 Smithkline Beecham P.L.C. Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
GB9715298D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
KR20010043455A (ko) 1998-06-30 2001-05-25 다케다 야쿠힌 고교 가부시키가이샤 당뇨병 치료용 약학적 조성물
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US6667064B2 (en) * 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7504118B2 (en) * 2003-04-11 2009-03-17 Fhg Corporation Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport
WO2006101325A1 (en) * 2005-03-19 2006-09-28 Se Young Chung A method for preparing extract for the prevention and treatment of hyperlipidemia and obesity from the extract of aster spathulifolius aerial part and composition containing the same
WO2012138214A1 (en) * 2011-04-08 2012-10-11 Brewster Lizzy Maritza Beta-guanidinopropionic acid for the treatment of hypertension
US12122736B2 (en) * 2012-10-18 2024-10-22 Nissan Foods Holdings Co., Ltd. Salty taste-enhancing agent and manufacturing method therefor, and salty taste-enhancing method
WO2021119316A1 (en) * 2019-12-11 2021-06-17 Rgenix, Inc. Methods of treating cancer
CN113598232A (zh) * 2021-07-05 2021-11-05 安徽科技学院 一种非发酵凝固型甜酒风味奶及其生产方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195199A (en) * 1966-11-25 1970-06-17 Horlicks Pharmaceuticals Ltd Improvements in Compositions comprising Insulin.
GB1195200A (en) * 1967-02-07 1970-06-17 Horlicks Pharmaceuticals Ltd Pharmaceutical Compositions.
US3843798A (en) * 1973-03-12 1974-10-22 Stanley Drug Products Inc Methods and compositions for inducing resistance to bacterial infections
GB1552179A (en) * 1976-11-02 1979-09-12 Beecham Group Ltd Pharmaceutical compositions for treating hyperglycaemia
US5053420A (en) * 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension
IT1237519B (it) * 1989-11-27 1993-06-08 Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
WO1991012799A1 (en) * 1990-02-28 1991-09-05 The Upjohn Company Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
GB9003185D0 (en) * 1990-02-13 1990-04-11 Ici Plc Pharmaceutical compositions

Also Published As

Publication number Publication date
ES2101866T3 (es) 1997-07-16
DE69219136T2 (de) 1997-08-28
EP0601001A1 (de) 1994-06-15
GR3023848T3 (en) 1997-09-30
ATE151634T1 (de) 1997-05-15
AU2479492A (en) 1993-03-16
DK0601001T3 (da) 1997-10-20
EP0601001B1 (de) 1997-04-16
WO1993003724A1 (en) 1993-03-04
JPH06510286A (ja) 1994-11-17
US5900435A (en) 1999-05-04

Similar Documents

Publication Publication Date Title
DE69219136D1 (de) Flüssiges nahrungsmittel, das 3-guanidinopropionsäure enthält
McElroy et al. Overview of the treatment of binge eating disorder
GEP20053538B (en) Pharmaceutical Composition Comprising A Combination of Metformin and Glyburide
US4619829A (en) Utilization of a single vitamin or a combination of various vitamins
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DZ1794A1 (fr) Nouvelle formule pharmaceutique.
HUP0002373A2 (hu) Glükagon antagonisták/inverz agonisták és ezeket tartalmazó gyógyászati készítmények
JPS61148121A (ja) 治療用組成物
Astwood et al. Treatment of hyperthyroidism with propylthiouracil
ATE290863T1 (de) Verwendung von prolactinmodulatoren und diät zur herstellung eines medikamentes zur behandlung der fettleibigkeit
HUT66826A (en) Human il-4 mutant proteins, thats containing pharmaceutical product and process for producing of proteins
Jordan et al. Hunger and satiety in humans during parenteral hyperalimentation
AU7077096A (en) Selective beta 3 adrenergic agonists
BR9915962A (pt) Composto da série do piridìnio, processos para a preparação de composto da série do piridìnio e de uma formulação parenteral, uso de um composto, composição farmacêutica para tratar complicações diabéticas e doenças associadas ao envelhecimento, e, método para tratar um paciente diabético e para prevenir ou tratar doenças causadas por complicações associadas à diabetes e ao envelhecimento
Maxeiner et al. Lethal suicidal intoxication with propafenone, after a history of self-inflicted injuries
RU94012067A (ru) Средство для лечения осложнений инсулинзависимого и инсулиннезависимого сахарного диабета
Walter Clinical impressions on treatment of obsessional states with intravenous clomipramine (Anafranil)
Mirtallo et al. Albumin in TPN solutions: potential savings from a prospective review
Reveno Thyrotoxicosis treated with thiouracil
US3565560A (en) Pharmaceutical preparation containing hydrofuramide and method of using it
US3449499A (en) Method for the reduction of glycemia
Bernheim et al. Carcinogens and oxidized fatty acids in the skin
COLWELL et al. Time action of globin insulin compared with that of protamine insulin modifications
US3740440A (en) Method of inhibiting appetite for food
CN108420824A (zh) 一种治疗糖尿病的产品及其制备与应用

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee